Moderna Inc (MRNA)
39.39
-0.17
(-0.43%)
USD |
NASDAQ |
Dec 20, 16:00
39.54
+0.15
(+0.38%)
After-Hours: 20:00
Moderna Free Cash Flow: -3.956B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| Novavax Inc | -112.35M |
| Biogen Inc | 1.768B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.566B |
| Cash from Investing (Quarterly) | 721.00M |
| Cash from Financing (Quarterly) | 11.00M |
| Free Cash Flow Per Share (Quarterly) | -4.303 |
| Free Cash Flow to Equity (Quarterly) | -1.717B |
| Free Cash Flow to Firm (Quarterly) | -1.717B |
| Free Cash Flow Yield | -25.97% |